Targeting AR Variant-Coactivator Interactions to Exploit Prostate Cancer Vulnerabilities

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-17-0280
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

YAP1 and AR Interactions Contribute to the Switch From Androgen-Dependent to Castration-Resistant Growth in Prostate Cancer

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2015English

Clinicopathologic Diagnostic Approach to Aggressive Variant Prostate Cancer

Archives of Pathology and Laboratory Medicine
MedicineForensic MedicinePathologyMedical Laboratory Technology
2020English

Pd32-09 Combination Effect of Therapies Targeting the Pi3k-Mtor and Ar Signaling Pathways in Prostate Cancer

Journal of Urology
Urology
2016English

Targeting Tim-1 to Circumvent Immune Tolerance in Prostate Cancer

2011English

Therapeutic Targeting of SPINK1-Positive Prostate Cancer

Science Translational Medicine
Medicine
2011English

Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Sigma1 Targeting to Suppress Aberrant Androgen Receptor Signaling in Prostate Cancer

Cancer Research
Cancer ResearchOncology
2017English

Mp99-19 Targeting Lncrna-Gas5 Suppresses Castration Resistant Prostate Cancer Cell Growth via Interaction and Suppression Androgen Receptor (Ar) Transactivation

Journal of Urology
Urology
2017English

216. Exploiting Redox-Based Vulnerabilities in Field Cancerization by Targeting Cancer Associated Fibroblasts

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy